ORBIMED ADVISORS LLC

Holdings History for Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Symbol: PASG on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 132,473 shares
Security Ownership %: 4.2%

Shares, Excluding Options vs Price

Value, Excluding Options

ORBIMED ADVISORS LLC ownership in Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG)

24 Jul 2025 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 132,473 shares of Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG). This represents 4.2% ownership of the company. In their previous filing dated 21 Jul 2025, ORBIMED ADVISORS LLC had reported owning 243,878 shares, indicating a decrease of +46%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ORBIMED ADVISORS LLC	4.2%	-45%	$53,029	132,473	-111,405	-46%	$0.40	13D/A	22 Jul 2025	24 Jul 2025, 17:44
ORBIMED ADVISORS LLC	7.8%	-17%	$97,624	243,878	-5,679,656	-96%	$0.40	13D/A	17 Jul 2025	21 Jul 2025, 17:28
ORBIMED ADVISORS LLC	9.5%	-11%	$1,954,766	5,923,534	-726,466	-11%	$0.33	13D/A	07 Jul 2025	09 Jul 2025, 20:06
ORBIMED ADVISORS LLC	11%	-11%	$2,194,500	6,650,000	-754,869	-10%	$0.33	13D/A	22 Apr 2025	25 Apr 2025, 19:48
ORBIMED ADVISORS LLC	12%		$2,443,607	7,404,869			$0.33	13D/A	20 Dec 2024	26 Dec 2024, 16:31

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0.06%	$0	0	-6,055,300	-100%	$8.03	Q3 2025
30 Jun 2025	0.06%	-0.01%	$2,423,937	6,055,300	-979,326	-14%	$0.40	Q2 2025
31 Mar 2025	0.06%	-0%	$2,483,926	7,034,626	-370,243		$0.35	Q1 2025
31 Dec 2024	0.09%	-0.03%	$4,199,301	7,404,869	-2,418,007	-25%	$0.57	Q4 2024
30 Sep 2024	0.13%	-0%	$6,876,013	9,822,876	-301,700	-3%	$0.70	Q3 2024
30 Jun 2024	0.17%	0%	$8,040,938	10,124,576	0		$0.79	Q2 2024
31 Mar 2024	0.27%	0%	$13,668,178	10,124,576	0		$1.35	Q1 2024
31 Dec 2023	0.2%	0%	$10,225,822	10,124,576	0		$1.01	Q4 2023
30 Sep 2023	0.15%	0%	$6,661,971	10,124,576	0		$0.66	Q3 2023
30 Jun 2023	0.19%	+0.02%	$9,530,263	10,124,576	+1,192,577	+13%	$0.94	Q2 2023
31 Mar 2023	0.17%	0%	$8,554,175	8,931,999	0		$0.96	Q1 2023
31 Dec 2022	0.25%	0%	$12,326,159	8,931,999	0		$1.38	Q4 2022
30 Sep 2022		0%	$11,165,000	8,931,999	0		$1.25 ^*	Q3 2022
30 Jun 2022	0.42%	+0.07%	$21,080,000	8,931,999	+1,600,000	+22%	$2.36	Q2 2022
31 Mar 2022	0.37%	+0.02%	$22,729,000	7,331,999	+369,100	+5.3%	$3.10	Q1 2022
31 Dec 2021	0.59%	0%	$44,214,000	6,962,899	0		$6.35	Q4 2021
30 Sep 2021	0.79%	0%	$69,350,000	6,962,899	0		$9.96	Q3 2021
30 Jun 2021	0.95%	0%	$92,189,000	6,962,899	0		$13.24	Q2 2021
31 Mar 2021	1.2%	0%	$121,711,000	6,962,899	0		$17.48	Q1 2021
31 Dec 2020	1.6%	0%	$178,041,000	6,962,899	0		$25.57	Q4 2020
30 Sep 2020	1.2%	0%	$91,284,000	6,962,899	0		$13.11	Q3 2020
30 Jun 2020	2.7%	0%	$190,296,000	6,962,899	0		$27.33	Q2 2020
31 Mar 2020	1.9%	+1.9%	$109,666,000	6,962,899	+6,962,899	NEW	$15.75	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.